Polygen Pharmaceuticals Inc., based in Edgewood, New York, is a rapidly growing generic pharmaceutical company engaged in the licensing, development, marketing, sale and distribution of generic pharmaceutical products for the U.S prescription drug market. Polygen Pharmaceuticals Inc, formed in 2015, owns a robust pipeline of products and will continue to introduce new generic products during the coming years as its pipeline matures through the regulatory approval cycle.